Kliničke studije za Melanom u državi Illinois
22 studija za Melanom traži sudionike na lokacijama u državi Illinois.
Gradovi u državi Illinois
- Chicago15 studija
- Evanston8 studija
- Aurora7 studija
- Cicero7 studija
- Peoria6 studija
- Champaign6 studija
- Decatur5 studija
- Waukegan5 studija
- Bloomington5 studija
- Danville5 studija
- Springfield5 studija
- Naperville5 studija
- Galesburg4 studija
- Charleston4 studija
- North Peoria4 studija
- Carbondale3 studija
Službeni tekst studije (engleski)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- OSF Saint Anthony's Health Center, Alton
- Rush-Copley Medical Center, Aurora
- Advocate Outpatient Center - Aurora, Aurora
- i još 54
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 40 do 75 godina · Oba spola · Ažurirano 2. lis 2026. · NCT05334069A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- University of Illinois Cancer Center, Chicago
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT06172478DESTINY-PANTUMOUR04
- Research Site, Decatur
U tijeku regrutacijaOpažajna studija
Od 18 do 130 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT07124000BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
- Rush-Copley Medical Center, Aurora
- Illinois CancerCare-Bloomington, Bloomington
- Illinois CancerCare-Canton, Canton
- i još 38
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT05136196A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
- Hope and Healing Cancer Services, Hinsdale
- Advocate Lutheran General Hospital, Park Ridge
- Illinois CancerCare, Peoria
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT06246916Pan-tumor MRD Study
- Cancer Care Specialists of Illinois (CCSI), O'Fallon
- Carle Health, Urbana
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 24. ruj 2026. · NCT06605404Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
- Loyola Center for Health at Burr Ridge, Burr Ridge
- Northwestern University, Chicago
- Swedish Covenant Hospital, Chicago
- i još 8
U tijeku regrutacijaFaza 3
Od 75 godina i više · Oba spola · Ažurirano 24. ruj 2026. · NCT07068074A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
- Saint Anthony's Health, Alton
- Rush - Copley Medical Center, Aurora
- Illinois CancerCare-Bloomington, Bloomington
- i još 33
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 15. ruj 2026. · NCT04511013Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer
- Northwestern University, Chicago
- Memorial Hospital East, Shiloh
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 31. kol 2026. · NCT05896839Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Lurie Children's Hospital-Chicago, Chicago
U tijeku regrutacijaFaza 1/2
12 Months – 30 Years · Oba spola · Ažurirano 25. kol 2026. · NCT04851119Project: Every Child for Younger Patients With Cancer
- Rush-Copley Medical Center, Aurora
- Lurie Children's Hospital-Chicago, Chicago
- Northwestern University, Chicago
- i još 16
U tijeku regrutacijaOpažajna studija
Do 25 godina · Oba spola · Ažurirano 25. kol 2026. · NCT02402244A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Orchard Healthcare Research Inc, Skokie
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 5. kol 2026. · NCT06330064Sun Exposure and Activities After Skin Cancer: Optimization of mHealth Interventions
- Northwestern University, Chicago
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 10. srp 2026. · NCT07556380A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
- Call for Information (Investigational Site 0024), Chicago
U tijeku regrutacijaFaza 1/2
6 Months – 17 Years · Oba spola · Ažurirano 6. srp 2026. · NCT02332668Integrated Cancer Repository for Cancer Research
- Rush-Copley Cancer Care Center, Aurora
- Rush-Copley Healthcare Center, Yorkville
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 19 do 110 godina · Oba spola · Ažurirano 29. lip 2026. · NCT02012699ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
- University of Chicago Medical Center, Chicago
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 13. svi 2026. · NCT03686124A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
- University of Chicago, Chicago
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 28. tra 2026. · NCT06413680A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
- Northwestern Memorial Hospital, Chicago
- University of Chicago Medical Center, Chicago
U tijeku regrutacijaFaza 2/3
Sve dobne skupine · Oba spola · Ažurirano 2. tra 2026. · NCT06581406Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- OSF Saint Anthony's Health Center, Alton
- Rush-Copley Medical Center, Aurora
- Advocate Outpatient Center - Aurora, Aurora
- i još 45
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 17. ožu 2026. · NCT06418204SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Chicago
U tijeku regrutacijaOpažajna studija
Sve dobne skupine · Oba spola · Ažurirano 28. lis 2025. · NCT03452774Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
- Advocate Illinois Masonic Medical Center, Chicago
- Northwestern Medicine Cancer Center Kishwaukee, DeKalb
- Northwestern University, Evanston
- i još 4
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 27. stu 2024. · NCT03860883Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
- Loyola University Medical Center, Maywood
U tijeku regrutacijaFaza 1
Od 18 do 89 godina · Oba spola · Ažurirano 12. ožu 2018. · NCT02870244Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.